Skip to main content

Advertisement

Table 2 Baseline characteristics for patients with and without subcutaneous tophi a

From: Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy

Demographics Patients with Patients without
  baseline tophi baseline tophi
(n= 155) (n= 57)
Males, n (%) 126 (82) 47 (81)
Whites, n (%) 106 (68) 37 (65)
Mean age, years (±SD) 56.7 (13.7) 51.9 (14.4)
Mean BMI, kg/m2 (±SD) 31.3 (6.6) 36.7 (8.6)
Mean baseline PUA, mg/dl (±SD) 9.8 (2.9) 9.4 (3.3)
  1. aBMI, body mass index; PUA, plasma uric acid.